Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Articles
Developing an Accurate Price Model for Personalized Medicines
Read More
Justifying the Value of Personalized Medicine
Read More
Impact of Pathways on Patient Outcomes
Read More
Improving Quality of Care Through Payer-Provider Collaborations
Read More
Incorporating ACOs in Oncology
Read More
Incorporation of Oncology into the Affordable Care Act
Read More
Integrating ACOs
Read More
Issues in Affordable Cancer Care
Read More
Issues in Medical Adherence
Read More
Practice Management
Impact of Glycemic Control on Healthcare Resource Utilization and Costs of Type 2 Diabetes: Current and Future Pharmacologic Approaches to Improving Outcomes
Stakeholder Perspective
Innovation in Patient Engagement and Management Is Critically Needed to Change Current Trends in Type 2 Diabetes
Read More
167
168
169
170
171
172
173
Page 170 of 244
Results 1691 - 1700 of 2434